Hjem › Follikulært lymfom › Kentucky
Kliniske studier for Follikulært lymfom i Kentucky
10 studier for Follikulært lymfom søker deltakere på steder i Kentucky.
Byer i Kentucky
Offisiell studietekst (engelsk)
Testing Addition of an Anti-cancer Drug, Vorasidenib to Temozolomide, After Radiation for Advanced Brain Cancer
- The James Graham Brown Cancer Center at University of Louisville, Louisville
- UofL Health Medical Center Northeast, Louisville
RekruttererFase 3
Alder 12 og eldre · Alle kjønn · Oppdatert 2. okt. 2026 · NCT07215910A Clinical Trial of MK-1045 and Rituximab in People With Follicular Lymphoma (MK-1045-007)
- University of Kentucky ( Site 1303), Lexington
RekruttererFase 2/3
Alder 18 og eldre · Alle kjønn · Oppdatert 25. sep. 2026 · NCT07634471A Study of Surovatamig (AZD0486) Plus Rituximab in Previously Untreated Follicular Lymphoma Patients
- Research Site, Lexington
- Research Site, Louisville
RekruttererFase 3
Alder 18 til 130 · Alle kjønn · Oppdatert 21. sep. 2026 · NCT06549595Study to Evaluate the Efficacy and Safety of [177Lu]Lu-DOTA-TATE in Patients With Grade 1 and Grade 2 Advanced GEP-NET
- St Elizabeth Healthcare, Edgewood
RekruttererFase 3
Alder 12 til 100 · Alle kjønn · Oppdatert 11. sep. 2026 · NCT06784752Testing the Addition of an Anti-Cancer Drug, Triapine, to the Usual Radiation Therapy for Recurrent Glioblastoma or Astrocytoma
- University of Kentucky/Markey Cancer Center, Lexington
RekruttererFase 1
Alder 18 og eldre · Alle kjønn · Oppdatert 2. sep. 2026 · NCT06860594SIGMA (Safusidenib in IDH1 Mutant Glioma Maintenance)
- University of Kentucky, Lexington
RekruttererFase 3
Alder 18 og eldre · Alle kjønn · Oppdatert 28. aug. 2026 · NCT05303519A Study of ARC-02 in B-cell NHL
- Norton Cancer Institute, Louisville
RekruttererFase 1
Alder 18 og eldre · Alle kjønn · Oppdatert 26. aug. 2026 · NCT07691606Study of Rondecabtagene Autoleucel in Aggressive Large B-Cell Lymphoma
- University of Louisville Brown Cancer Center, Louisville
RekruttererFase 1/2
Alder 18 og eldre · Alle kjønn · Oppdatert 25. aug. 2026 · NCT05826535A Study to Compare the Efficacy and Safety of Golcadomide in Combination With Rituximab (Golca + R) vs Investigator's Choice in Participants With Relapsed/Refractory Follicular Lymphoma Who Have Received at Least 1 Prior Line of Systemic Therapy (GOLSEEK-4)
- Local Institution - 0218, Lexington
RekruttererFase 3
Alder 18 og eldre · Alle kjønn · Oppdatert 20. mai 2026 · NCT06911502The OPAL Study: AVM0703 for Treatment of Lymphoid Malignancies
- Norton Cancer Institute, Louisville
RekruttererFase 1/2
Alder 12 til 95 · Alle kjønn · Oppdatert 15. apr. 2026 · NCT04329728Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.